CA3176584A1 - Silver salt-containing ophthalmic aqueous composition filled in resin container - Google Patents
Silver salt-containing ophthalmic aqueous composition filled in resin containerInfo
- Publication number
- CA3176584A1 CA3176584A1 CA3176584A CA3176584A CA3176584A1 CA 3176584 A1 CA3176584 A1 CA 3176584A1 CA 3176584 A CA3176584 A CA 3176584A CA 3176584 A CA3176584 A CA 3176584A CA 3176584 A1 CA3176584 A1 CA 3176584A1
- Authority
- CA
- Canada
- Prior art keywords
- aqueous composition
- ophthalmic aqueous
- ophthalmic
- present
- based resin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1468—Containers characterised by specific material properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Bridges Or Land Bridges (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020062252 | 2020-03-31 | ||
| JP2020-062252 | 2020-03-31 | ||
| PCT/JP2021/007366 WO2021199814A1 (ja) | 2020-03-31 | 2021-02-26 | 樹脂製容器に充填された銀塩含有眼科用水性組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3176584A1 true CA3176584A1 (en) | 2021-10-07 |
Family
ID=77930318
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3176584A Pending CA3176584A1 (en) | 2020-03-31 | 2021-02-26 | Silver salt-containing ophthalmic aqueous composition filled in resin container |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230145529A1 (https=) |
| EP (1) | EP4129341A4 (https=) |
| JP (4) | JP7053966B2 (https=) |
| KR (2) | KR20240135080A (https=) |
| CN (1) | CN115348871B (https=) |
| CA (1) | CA3176584A1 (https=) |
| TW (1) | TWI896607B (https=) |
| WO (1) | WO2021199814A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022044701A (ja) * | 2022-01-24 | 2022-03-17 | 参天製薬株式会社 | インジェクションブロー成形されたマルチドーズ型点眼容器に収容される水性懸濁液 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI231759B (en) * | 2001-06-27 | 2005-05-01 | Alcon Inc | Olopatadine formulations for topical administration |
| JP4683835B2 (ja) * | 2003-12-01 | 2011-05-18 | ロート製薬株式会社 | 防腐剤及びこれを含有する水性組成物 |
| KR100557679B1 (ko) * | 2004-01-07 | 2006-03-07 | 뉴바이오 (주) | 4차암모늄의 공중합에 의한 콘택트렌즈제조방법 |
| JP4856392B2 (ja) | 2004-04-23 | 2012-01-18 | ロート製薬株式会社 | 防腐剤及びこれを含有する水性組成物 |
| JP2006162648A (ja) | 2004-12-02 | 2006-06-22 | Konica Minolta Business Technologies Inc | 現像装置及び画像形成装置 |
| US9629852B2 (en) * | 2007-10-16 | 2017-04-25 | Sun Pharma Advanced Research Company Ltd. | Ophthalmic composition comprising a prostaglandin |
| JP5345743B1 (ja) * | 2012-02-27 | 2013-11-20 | ロート製薬株式会社 | 眼科用組成物キット |
| WO2014126267A1 (en) | 2013-02-15 | 2014-08-21 | Senju Pharmaceutical Co., Ltd. | Difluprednate emulsion composition containing antimicrobial metal |
| CN105073112B (zh) * | 2013-03-13 | 2017-12-29 | 参天制药株式会社 | 睑板腺功能障碍的治疗剂 |
| KR102330736B1 (ko) * | 2014-12-25 | 2021-11-23 | 산텐 세이야꾸 가부시키가이샤 | 수성 점안액 |
| JP6611444B2 (ja) * | 2015-03-24 | 2019-11-27 | ロート製薬株式会社 | 眼科用組成物 |
| WO2016195073A1 (ja) | 2015-06-05 | 2016-12-08 | 参天製薬株式会社 | 水性点眼液 |
| JP6615548B2 (ja) * | 2015-08-06 | 2019-12-04 | ロート製薬株式会社 | 眼科組成物 |
| WO2019107569A1 (ja) * | 2017-12-01 | 2019-06-06 | 参天製薬株式会社 | 眼科用製品 |
| WO2020004247A1 (ja) * | 2018-06-28 | 2020-01-02 | 株式会社Ｃｓｐアドバンスソリューションズ | 流行性角結膜炎の治療用点眼剤、当該点眼剤を生成するプラズマ活性点眼剤生成装置、及び流行性角結膜炎の治療方法 |
| JP7139206B2 (ja) | 2018-09-21 | 2022-09-20 | 小林製薬株式会社 | 医薬組成物 |
-
2021
- 2021-02-26 CA CA3176584A patent/CA3176584A1/en active Pending
- 2021-02-26 WO PCT/JP2021/007366 patent/WO2021199814A1/ja not_active Ceased
- 2021-02-26 KR KR1020247029902A patent/KR20240135080A/ko active Pending
- 2021-02-26 CN CN202180026304.3A patent/CN115348871B/zh active Active
- 2021-02-26 EP EP21781950.7A patent/EP4129341A4/en active Pending
- 2021-02-26 TW TW110107071A patent/TWI896607B/zh active
- 2021-02-26 JP JP2021552932A patent/JP7053966B2/ja active Active
- 2021-02-26 US US17/914,976 patent/US20230145529A1/en active Pending
- 2021-02-26 KR KR1020227037013A patent/KR102705675B1/ko active Active
-
2022
- 2022-03-31 JP JP2022058115A patent/JP7169477B2/ja active Active
- 2022-10-26 JP JP2022171413A patent/JP7721498B2/ja active Active
-
2025
- 2025-07-29 JP JP2025126160A patent/JP2025146955A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2025146955A (ja) | 2025-10-03 |
| TWI896607B (zh) | 2025-09-11 |
| JP7169477B2 (ja) | 2022-11-10 |
| JP2022087168A (ja) | 2022-06-09 |
| CN115348871B (zh) | 2025-08-08 |
| JP2023001184A (ja) | 2023-01-04 |
| EP4129341A4 (en) | 2024-04-24 |
| CN115348871A (zh) | 2022-11-15 |
| JP7721498B2 (ja) | 2025-08-12 |
| US20230145529A1 (en) | 2023-05-11 |
| TW202203920A (zh) | 2022-02-01 |
| JPWO2021199814A1 (https=) | 2021-10-07 |
| KR20220161379A (ko) | 2022-12-06 |
| JP7053966B2 (ja) | 2022-04-12 |
| KR20240135080A (ko) | 2024-09-10 |
| EP4129341A1 (en) | 2023-02-08 |
| WO2021199814A1 (ja) | 2021-10-07 |
| KR102705675B1 (ko) | 2024-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6903448B2 (ja) | ドルゾラミドとブリモニジンを含む医薬組成物 | |
| JP2025146955A (ja) | 樹脂製容器に充填された銀塩含有眼科用水性組成物 | |
| KR102075173B1 (ko) | 보존 효력을 갖는 브롬페낙 수성 액제 조성물 | |
| JP2023093601A (ja) | 眼科用製品 | |
| JP2022180452A (ja) | レバミピドまたはその塩および高分子を含有する水性懸濁液 | |
| JP6702754B2 (ja) | ドルゾラミドを含有する防腐剤 | |
| TW202604499A (zh) | 填充於樹脂製容器之含銀鹽眼科用水性組合物 | |
| US11324829B2 (en) | Antiseptic agent comprising meglumine or salt thereof | |
| JP6877613B2 (ja) | 防腐効果のある医薬の組合せ | |
| JP4892291B2 (ja) | 眼科用防腐組成物 | |
| JP2023155169A (ja) | 眼科用水性組成物 | |
| WO2023204297A1 (ja) | セペタプロストを含有する眼科用組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD Year of fee payment: 4 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250121 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20250121 Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250121 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED Effective date: 20250219 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250219 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT Effective date: 20250303 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT Effective date: 20250430 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20250508 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 5TH ANNIV.) - STANDARD Year of fee payment: 5 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20260128 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20260128 |